11/18/2025
🚨 Major New Study: Amyloid Blood Clots Found in 100% of COVID-Vaccinated Participants, Spike Protein Alone Proven to Cause Them in the Lab
A new paper just published in the Journal of Medical Virology (November 2025) has delivered one of the clearest signals yet on persistent clotting issues after COVID vaccination.
Researchers examined blood samples from 88 people, 94% of whom were vaccinated.
Using fluorescence microscopy and Thioflavin-T staining (the gold standard for detecting amyloid), they found abnormal, breakdown-resistant amyloid microclots in every single vaccinated individual.
These same structures were essentially absent in the small unvaccinated control group.
In participants with ongoing symptoms (many diagnosed as Long COVID, though vaccination status dominated the cohort), the clot burden was dramatically higher: total amyloid area up to 20× greater, with large and very large clots present in nearly all cases.
The clots contained trapped inflammatory markers, immune cell debris, and DNA—features that can restrict blood flow and drive chronic inflammation.
The strongest evidence came from the lab: adding purified SARS-CoV-2 spike protein (the same protein produced by mRNA and vector vaccines) to normal fibrinogen immediately triggered the formation of identical amyloid clots.
This confirms that spike protein exposure by itself, independent of viral infection, is sufficient to induce the pathology.
These findings align closely with the large, white, fibrous clots reported by embalmers since 2021 and provide a plausible mechanism for a range of post-vaccination symptoms involving fatigue, cognitive difficulties, and cardiovascular strain.
This is the first study to show 100% prevalence of these abnormal clots in a vaccinated cohort and the first to reproduce them reliably using only spike protein.
The authors emphasize the need for larger confirmatory studies, routine screening of clotting and inflammatory markers in symptomatic patients, and renewed attention to long-term vascular and neurological risks.
🔗 Article: https://www.thefocalpoints.com/p/breaking-study-anomalous-amyloid?
🔗 Study: https://onlinelibrary.wiley.com/doi/10.1002/jmv.70613
